Jazz Pharmaceuticals plc
Symbol: JAZZ
NASDAQ
124.79
USDMarktpreis heute
16.5122
P/E-Verhältnis
0.0368
PEG-Verhältnis
7.78B
MRK Kapital
- 0.00%
DIV Rendite
Jazz Pharmaceuticals plc (JAZZ) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 5742.22 | 1626.3 | 881.5 | 591.4 | |||||||||||||||||||
balance-sheet.row.short-term-investments | 930 | 420 | 30 | 0 | |||||||||||||||||||
balance-sheet.row.net-receivables | 2567.96 | 705.8 | 651.5 | 563.4 | |||||||||||||||||||
balance-sheet.row.inventory | 2540.86 | 597 | 714.1 | 1072.7 | |||||||||||||||||||
balance-sheet.row.other-current-assets | 754.22 | 334.8 | 267.2 | 252.4 | |||||||||||||||||||
balance-sheet.row.total-current-assets | 12304.18 | 3263.9 | 2606.1 | 2611.3 | |||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 1123.89 | 235 | 301.4 | 343.4 | |||||||||||||||||||
balance-sheet.row.goodwill | 6924.57 | 1753.1 | 1692.7 | 1827.6 | |||||||||||||||||||
balance-sheet.row.intangible-assets | 22305.88 | 5418 | 5794.4 | 7152.3 | |||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 29230.45 | 7171.2 | 7487.1 | 8979.9 | |||||||||||||||||||
balance-sheet.row.long-term-investments | 25.24 | 4.7 | 5.5 | 12 | |||||||||||||||||||
balance-sheet.row.tax-assets | 1771.38 | 477.8 | 376.2 | 311.1 | |||||||||||||||||||
balance-sheet.row.other-non-current-assets | 449.94 | 240.7 | 58.9 | 40.8 | |||||||||||||||||||
balance-sheet.row.total-non-current-assets | 32600.91 | 8129.4 | 8229.1 | 9687.3 | |||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.total-assets | 44905.09 | 11393.4 | 10835.3 | 12298.6 | |||||||||||||||||||
balance-sheet.row.account-payables | 436.48 | 102.8 | 90.8 | 100.3 | |||||||||||||||||||
balance-sheet.row.short-term-debt | 1324.61 | 624.4 | 31 | 31 | |||||||||||||||||||
balance-sheet.row.tax-payables | 231.72 | 35.1 | 7.7 | 9.6 | |||||||||||||||||||
balance-sheet.row.long-term-debt-total | 21794.59 | 5108 | 5765.2 | 6106.1 | |||||||||||||||||||
Deferred Revenue Non Current | 64.26 | 64.3 | 0 | 0.5 | |||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 3531.91 | - | - | - | |||||||||||||||||||
balance-sheet.row.other-current-liab | 3168.01 | 774.5 | 811 | 675.9 | |||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 25853.81 | 6119.7 | 6816.3 | 7524.1 | |||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 297.5 | 64.3 | 71.8 | 87.2 | |||||||||||||||||||
balance-sheet.row.total-liab | 30818 | 7656.4 | 7749.5 | 8333.4 | |||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.common-stock | 0.24 | 0.1 | 0.1 | 0.1 | |||||||||||||||||||
balance-sheet.row.retained-earnings | 3377.81 | 878.7 | 733.6 | 830.2 | |||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -3724.13 | -841.7 | -1125.5 | -400.4 | |||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 14433.16 | 3700 | 3477.6 | 3535.3 | |||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 14087.09 | 3737 | 3085.7 | 3965.2 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 44905.09 | 11393.4 | 10835.3 | 12298.6 | |||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.total-equity | 14087.09 | 3737 | 3085.7 | 3965.2 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 44905.09 | - | - | - | |||||||||||||||||||
Total Investments | 940.2 | 424.7 | 35.5 | 12 | |||||||||||||||||||
balance-sheet.row.total-debt | 23183.46 | 5796.7 | 5796.2 | 6137.1 | |||||||||||||||||||
balance-sheet.row.net-debt | 18191.25 | 4590.3 | 4914.7 | 5545.7 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 414.83 | 414.8 | -224.1 | -329.7 | |||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 638.7 | 638.7 | 629.5 | 552.5 | |||||||||||||||||||
cash-flows.row.deferred-income-tax | -260.22 | -260.2 | -292.3 | 69.2 | |||||||||||||||||||
cash-flows.row.stock-based-compensation | 226.84 | 226.8 | 222 | 189 | |||||||||||||||||||
cash-flows.row.change-in-working-capital | -204.44 | -204.4 | 9.9 | -48 | |||||||||||||||||||
cash-flows.row.account-receivables | -51.88 | -51.9 | -90.1 | -92.7 | |||||||||||||||||||
cash-flows.row.inventory | -13.42 | -13.4 | -49.6 | -48.9 | |||||||||||||||||||
cash-flows.row.account-payables | 9.6 | 9.6 | -11.2 | 57 | |||||||||||||||||||
cash-flows.row.other-working-capital | -148.74 | -148.7 | 160.9 | 36.6 | |||||||||||||||||||
cash-flows.row.other-non-cash-items | 276.29 | 276.3 | 926.9 | 345.4 | |||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 1092.01 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -24.96 | -24 | -498.2 | -45.5 | |||||||||||||||||||
cash-flows.row.acquisitions-net | -20 | 0 | 53 | -6234.8 | |||||||||||||||||||
cash-flows.row.purchases-of-investments | -390.1 | -390.1 | -61 | -26.8 | |||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 270 | 270 | 60 | 1095 | |||||||||||||||||||
cash-flows.row.other-investing-activites | 2 | -19 | 0 | 0 | |||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -163.06 | -163.1 | -446.2 | -5212.1 | |||||||||||||||||||
cash-flows.row.debt-repayment | -31 | -31 | -582 | -1320.6 | |||||||||||||||||||
cash-flows.row.common-stock-issued | 46.46 | 46.5 | 98 | 135.3 | |||||||||||||||||||
cash-flows.row.common-stock-repurchased | -313.03 | -269.8 | -0.1 | -35.6 | |||||||||||||||||||
cash-flows.row.dividends-paid | -112.28 | 0 | -98 | -99.7 | |||||||||||||||||||
cash-flows.row.other-financing-activites | 104.59 | -51 | 52.6 | 5291.1 | |||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -305.25 | -305.3 | -529.5 | 3970.5 | |||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 1.14 | 1.1 | -6.2 | -3.2 | |||||||||||||||||||
cash-flows.row.net-change-in-cash | 634.83 | 354.8 | 290 | -466.3 | |||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 4992.22 | 1206.3 | 881.5 | 591.4 | |||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 4357.39 | 851.5 | 591.4 | 1057.8 | |||||||||||||||||||
cash-flows.row.operating-cash-flow | 1092.01 | 1092 | 1272 | 778.5 | |||||||||||||||||||
cash-flows.row.capital-expenditure | -24.96 | -24 | -498.2 | -45.5 | |||||||||||||||||||
cash-flows.row.free-cash-flow | 1067.05 | 1068 | 773.8 | 733 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 3834.2 | 3834.2 | 3659.4 | 3094.2 | ||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 587.13 | 1043.9 | 540.5 | 440.8 | ||||||||||||||||||||
income-statement-row.row.gross-profit | 3247.07 | 2790.3 | 3118.9 | 2653.5 | ||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||
income-statement-row.row.research-development | 849.66 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-expenses | 1286.53 | 1476.9 | 599.2 | 525.8 | ||||||||||||||||||||
income-statement-row.row.operating-expenses | 2587.77 | 2131.1 | 2606.6 | 2483.2 | ||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 3174.9 | 3174.9 | 3147.1 | 2924 | ||||||||||||||||||||
income-statement-row.row.interest-income | 65.2 | 65.1 | 11.5 | 1.8 | ||||||||||||||||||||
income-statement-row.row.interest-expense | 308.77 | 351.1 | 288.2 | 278.8 | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -215.41 | -361.4 | -885.1 | -283.1 | ||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 1286.53 | 1476.9 | 599.2 | 525.8 | ||||||||||||||||||||
income-statement-row.row.total-operating-expenses | -215.41 | -361.4 | -885.1 | -283.1 | ||||||||||||||||||||
income-statement-row.row.interest-expense | 308.77 | 351.1 | 288.2 | 278.8 | ||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 632.12 | 638.7 | 599.2 | 525.8 | ||||||||||||||||||||
income-statement-row.row.ebitda-caps | 1290.43 | - | - | - | ||||||||||||||||||||
income-statement-row.row.operating-income | 658.31 | 659.3 | 512.3 | 170.3 | ||||||||||||||||||||
income-statement-row.row.income-before-tax | 297.93 | 297.9 | -372.8 | -112.8 | ||||||||||||||||||||
income-statement-row.row.income-tax-expense | -119.91 | -119.9 | -158.6 | 216.1 | ||||||||||||||||||||
income-statement-row.row.net-income | 414.83 | 414.8 | -214.1 | -329 |
Häufig gestellte Frage
Wie hoch ist die Jazz Pharmaceuticals plc (JAZZ) Gesamtvermögen?
Jazz Pharmaceuticals plc (JAZZ) Gesamtvermögen ist 11393359000.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist 1984075000.000.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.847.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist 17.051.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist 0.108.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist 0.172.
Was ist der Jazz Pharmaceuticals plc (JAZZ) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist 414832000.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 5796653000.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 2131063000.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 1206310000.000.